Bio-Techne Corp (TECH) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Bio-Techne Corp (US:TECH), currently being evaluated. In 2025, Bio-Techne Corp generated $1.22 Billion in revenue and $256.55 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Bio-Techne Corp is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: N/A
- Recent Revenue (2025): $1.22 Billion
- Free Cash Flow (2025): $256.55 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.